Open Access is an initiative that aims to make scientific research freely available to all. To date our community has made over 100 million downloads. It’s based on principles of collaboration, unobstructed discovery, and, most importantly, scientific progression. As PhD students, we found it difficult to access the research we needed, so we decided to create a new Open Access publisher that levels the playing field for scientists across the world. How? By making research easy to access, and puts the academic needs of the researchers before the business interests of publishers.
We are a community of more than 103,000 authors and editors from 3,291 institutions spanning 160 countries, including Nobel Prize winners and some of the world’s most-cited researchers. Publishing on IntechOpen allows authors to earn citations and find new collaborators, meaning more people see your work not only from your own field of study, but from other related fields too.
The physiological vulnerability of specific tissues to radionuclides must directly dictate the molecular design of waste containment chemistries. Unlike conventional reviews that treat radiobiology and radiochemistry separately, we establish a continuous feedback loop between cellular injury mechanisms (e.g., strontium-90 in pancreatic β‑cells via calcium mimicry) and chemical sequestration strategies (e.g., cryptand‑2.2.2‑functionalized geopolymers). We first reinterpret fundamental radionuclide properties through a physiological lens, revealing why half‑life alone fails to predict biological risk. Second, we propose a Physiological Vulnerability Index (PVI) that quantifies how ion‑mimicry and organ‑specific transport proteins (e.g., sodium iodide symporter (NIS), transient receptor potential vanilloid 6 (TRPV6), Na+/K+‑ATPase) amplify hazard beyond standard dosimetry, using the effective half-life of each radionuclide (combining physical and biological half-life) rather than physical half-life alone. Third, we design waste forms using reverse physiology: supramolecular hosts that replicate the failed selectivity of biological channels, radiation‑tolerant geopolymers that block mitochondrial fragmentation, and redox‑active barriers that disrupt ferroptosis triggered by plutonium. Finally, we introduce the Biocompatible Waste Matrix Score (BWMS) – a hybrid metric that combines chemical leach rate with a panel of five physiological biomarkers (mtDNA fragments, insulin secretion inhibition, thyroid NIS silencing, lymphocyte γ‑H2AX foci, and plasma selenoprotein P). This review transforms radioactive waste management from a purely geochemical discipline into a biology‑driven engineering field, offering testable hypotheses for next‑generation containment systems.
Radioisotope Department, Egyptian Atomic Energy Authority, Nuclear Research Center, Cairo, Egypt
Hosam M. Saleh
*
Radioisotope Department, Egyptian Atomic Energy Authority, Nuclear Research Center, Cairo, Egypt
Aleksandr S. Doroshkevich
Joint Institute for Nuclear Research (JINR), Dubna, Russia
Zhanna V. Mezentseva
Joint Institute for Nuclear Research (JINR), Dubna, Russia
*Address all correspondence to: hosam.saleh@eaea.org.eg
1. Introduction
The global volume of radioactive waste is increasing on a continuous basis. According to the IAEA report of 2021, it was estimated that High-Level Waste (HLW) produced by all nuclear power plants worldwide was over 30 tonnes and Intermediate-Level Waste (ILW) is approximately 370,000 tonnes annually [1]. For Europe, projections show significant growth in waste volumes to at least 2030 as reactors shut down and decommissioning accelerates [2]. In addition, deep geological repositories (DGR) are considered a permanent technical solution for the isolation of HLW and ILW; therefore, they have become an internationally agreed upon objective for the safe management of HLW and ILW. An example of DGRs being used is Finland’s Onkalo Facility, which is the first operational DGR [1]. Other countries are also progressing satisfactorily towards developing a DGR, including but not limited to those of the Swedish Nuclear Fuel and Waste Management Company [3], the French National Agency for Radioactive Waste Management [4, 5], and the Canadian Nuclear Waste Management Organization (NWMO, site selection planned for 2024) (as published in ANS Nuclear Newswire, 2025)[6]. With respect to national programs, borosilicate glass is generally taken as the reference high-level waste (HLW) waste form [6]. There has been investigation into geopolymers, which are alkali-activated inorganic (aluminosilicate) binders, to determine their possible use as alternative or complementary HLW containment materials. Compared with standard borosilicate glass, geopolymers can provide a number of advantages. These include: enhanced resistance to acids, reduced temperatures required for production, and possible capability to immobilize Cs+ and Sr2+ through either physical encapsulation or ion-exchange [7, 8]. There is Currently a considerable amount of work being done in supramolecular chemistry within the glass science community and, as part of that effort, there has been developed a large number of molecules called macrocyclic hosts (e.g. cryptands; cucurbit[n]urils; and crown ethers) that exhibit significant thermodynamic selectivity for certain radionuclides over conventional mineral sorbents [9, 10]. Despite these chemical advances, the conceptual framework connecting waste form chemistry to biological safety has remained underdeveloped. Regulatory test standards such as ASTM C1285 (Product Consistency Test) and ASTM C1308 (Accelerated Leach Test) measure total radionuclide mass release a proxy for environmental hazard, not a direct measure of biological risk. This review argues that a more coherent framework requires explicit mapping of radionuclide toxicity mechanisms onto containment chemistry: understanding why a given radionuclide is harmful at the cellular and molecular levels should drive the design of materials that prevent that harm, not merely reduce mass release.
2.1 Rethinking fundamental properties through a biological filter
Conventional nuclear descriptions (half-life, decay mode, particular activity) attain physiological significance just when integrated with the mechanisms by which a radionuclide accesses, binds to, and interacts inside tissues. The documents correlate these physical properties closely with biokinetics, tissue permeability, and target-mimicking chemistry in imaging and therapy. The “optimal” physical half-life depends on uptake and washout in tumor vs normal tissues; too short wastes decays in transit, too long irradiates non-target tissues and the environment [11]. For instance, while uranium-238 isotope 238U has a half-life of 4.5 billion years, barium-90 isotope ⁹⁰Sr has a half-life of 28.8 years which results in greater exposure to barium-90 isotope within biological systems (e.g., binding to hydroxyapatite) through calcium absorption and its interaction with calmodulin [a calcium-binding protein that, through its ability to bind both Ca2+ and ⁹⁰Sr, retains more of these isotopes than would be predicted by physical decay properties alone].
Physical half-life alone is an incomplete basis for a physiological vulnerability metric, since it ignores how long a radionuclide is actually retained in the tissue that matters. The index below therefore uses the effective half-life, Teff = (Tr × Tb)/(Tr + Tb), where Tr is the physical (radiological) half-life and Tb is the biological half-life in the relevant tissue or organ, in place of T1/2 alone.
As a result of this comparison between these two radioisotopes, a new index of “Physiological Vulnerability” (PVI) may be determined:
PVI=log10(TeffXAspecXSXURDNA)
Where:
Teff = effective half-life (Tr × Tb)/(Tr + Tb), years, normalized against ⁹⁰Sr
A spec = specific activity (Bq/g),
S = solubility in biological solutions (g/L at pH 7.4, 37 °C),
U = fraction of uptake through transporters of both isotopes and their biological significance (0-1),
R DNA = repair capability of DNA in target tissues compared to fibroblasts.
In rabbits administered with ⁹⁰Sr and 45Ca, beginning bone uptake at 10 minutes was comparable; however, the timing and magnitude of maximum uptake varied: 45Ca peaked at 1 day, whereas ⁹⁰Sr peaked at 4 hours, with the maximum uptake of 45Ca exceeding that of ⁹⁰Sr. Areas characterized by elevated bone turnover (trabecular bone, bone extremities) exhibited increased turnover of both isotopes; nonetheless, these regions demonstrated reduced stable Sr/Ca ratios, suggesting a preferred long-term retention of calcium relative to strontium [12]. In vitro, bone exposed to solutions containing 45Ca and 85Sr took up more calcium than strontium; Ca/Sr uptake ratios were typically 1.2–1.4 and could reach ≥ 2 when stable Sr was added [13]. This behavior was similar for human and canine bone, bone powder, ashed bone, ethylenediamine‑treated bone, and apatite 2. Up to ~ 10 at% Sr2+ can enter the HA lattice without phase segregation, similar to physiological limits in bone. Higher Sr2+ levels favor formation of a Sr‑rich amorphous calcium phosphate (Sr(ACP)), which coexists with hydroxyapatite (HA) and is particularly stabilized at high Sr. Sr2+ incorporation induces lattice disorder and changes carbonate substitution patterns in HA, linking high Sr doses to mineral defects and pathologies such as osteomalacia in animal models [14]. When examining this index, physiological threats between these isotopes emerge with much greater vulnerability for both Sr and I (PVI = 2.3 for Sr and PVI = 2.1 for I) than Cs (PVI = 1.2). Even though the half-lives of these three radioisotopes are approximately equal, greater physiological threat exists from both Sr and I because of the mechanism of active transport (Sr using TRPV6; I using NIS) utilized to retain their presence in biological systems. In comparison, Cs distributes through biological systems via distribution uniformity, but Cs is only partially excluded from the cellular membrane by means of Na +/K + ATPase (sodium-potassium pump). PVI for other key radionuclides are summarized in Table 1.
Radionuclide
Half-life (years)
Ion mimicry
Primary transporter
Target organ
PVI
Tb Support
⁹⁰Sr
28.8
Ca2+
TRPV6, CaM
Bone, pancreas
2.3
Not reported
12⁹I
1.57 × 10⁷
I⁻
NIS (SLC5A5)
Thyroid
2.1
Not reported
22⁶Ra
1600
Ca2+
TRPV6, αvβ3 integrin
Bone, marrow
1.9
Not reported
23⁹Pu
2.41 × 10⁴
Fe3+
Transferrin receptor
Liver, macrophages
1.8
Not reported
13⁷Cs
30.2
K+
Na+/K+ ATPase
Muscle, heart
1.2
Not reported
⁹⁹Tc
2.11 × 105
TcO4⁻ (anion)
Anion channels
Thyroid, gut
0.9
Not reported
3H (HTO)
12.3
H2O
Aquaporin
Whole body
0.4
Not reported
Table 1.
Physiological vulnerability index (PVI) for selected radionuclides.
This PVI framework immediately shows that physiological risk is not a simple function of radioactivity. It prioritizes radionuclides that exploit active uptake mechanisms and incorporate into essential biological structures. Isotopic half-life in animal tissues varies with body mass, tissue type, and taxon, which implies biological residence times are tissue-dependent rather than fixed constants across the body [15].
2.2 Non‑canonical physiological mechanisms
2.2.1 Radionuclide mimicry: Disruption of endocrine (thyrocyte and pancreas) disruption via radionuclide mimicry
Sodium Iodide Symporter (NIS) is an intrinsic plasma membrane glycoprotein on the basolateral surface of thyroid follicular cells, co-transporting 2 Na+ with 1 I⁻ using the Na+ gradient from Na+/K+-ATPase [16, 17]. NIS is responsible for concentrating iodine in the thyroid gland about 20 to 40 times more than NIS can usually produce when looking at concentration levels in serum [16]. NIS will also concentrate both types of radioactive iodine (long- (I-129) and short-lived (I-131)) regardless of their physical properties. More recently, data from the global cohort of exposed individuals post-Chernobyl has revealed that chronic or low-level exposure to radioactive iodine will result in long-term effects by leading to hypermethylation within the NIS gene’s promoter, thereby rendering it epigenetically silenced and producing hypothyroid symptoms after the radioactive material has decayed away. This creates a positive feedback loop in which a decrease in trapping of iodine results in an increase in retention of other radioiodines and pertechnetate in the body. Environmental anions such as perchlorate, thiocyanate, and nitrate competitively inhibit NIS and can disrupt thyroid hormone synthesis [18].
Strontium‑90 is even more insidious. Strontium ions move into blood from gut through TRPV6 calcium channels and are deposited in bone as hydroxyapatite over many years (biological half-life). More recent information reveals that they also deposit in pancreatic β-cells. Insulin release is triggered by calcium signalling in response to glucose. Calmodulin’s shape and affinity for calcium-dependent protein kinase II (CaMKII) are altered when strontium ions replace calcium ions [19]. Inhibiting CaMKII in β-cells reduces glucose-stimulated Ca2+ entry, lowers endoplasmic reticulum (ER) and cytosolic Ca2+, suppresses action potential firing, and markedly impairs glucose-stimulated insulin secretion (GSIS) and glucose tolerance in mice [19]. Direct research does not currently exist on the influence of radioactive Sr-90 on the secretion of insulin from pancreatic islets isolated from mice at environmentally relevant levels of contaminants. Stable (nonradioactive) strontium has been shown to substitute for calcium in stimulating insulin secretion at millimolar concentrations (approximately 2.5 mM or 2.5 million times higher than 0.5 nM) in in vitro studies, but the magnitude of stimulation with strontium is much lower than that of calcium. There is a correlation in epidemiologic studies between abdominal radiation and the risk of developing diabetes; however, there is no definitive proof that environmental exposure to Sr-90 decreases insulin secretion or raises the risk of metabolic syndrome. This is an important area for further study [20]. Although no direct experimental evidence currently links environmental Sr‑90 exposure to metabolic syndrome or type 2 diabetes, existing radiological protection regulations (e.g., ICRP, IAEA) focus exclusively on bone and marrow doses and cancers such as osteosarcoma and leukemia. The possibility of pancreatic or metabolic effects has not been systematically investigated and therefore remains unrecognized.
2.2.2 Mitochondrial dynamics as a sensitive radiobiological target
Conventional dosimetry focuses on nuclear DNA double‑strand breaks. Mitochondria have their own circular genome (mtDNA, 16.6kb), as well as limited repair capabilities [21, 22]. Human mtDNA lacks histones, has fewer repair pathways, and notably no canonical nucleotide excision repair; base excision repair is present but limited compared with the nucleus [23, 24]. Chronic beta-emitter (ie: 13⁷Cs and 90Sr) exposure leads to continuous production of ROS, primarily damaging mtDNA. The threshold for physiological effect is lower than for nuclear DNA damage [25].
When stress activates the inflammasome, mitochondrial DNA (mtDNA) is oxidized, losing or breaking into small pieces (fragments) about 500-650 bp in length. These mtDNA fragments exit the mitochondrion through two different routes. One route is by passing through the mitochondrial permeability transition pore (mPTP). The other route is via the opening of voltage-dependent anion channel (VDAC) oligomers found in non-apoptotic macrophages [26]. mPTP generally only allows molecules < 1.5 kDa to cross the membranes, meaning that whole nucleoids can’t cross directly – only mtDNA fragments – and that the long-term opening of the mPTP will likely cause a rupture in the membrane [27]. Live cells with stressed mtDNA have also shown a release of free intra-mtDNA fragments from the VDAC oligomers that are enriched in the D-loop region, with peaks around 110 bp – these DNA fragments can seed both circulating mtDNA and mtDNA found in the cytosol of the cells [28]. In cases of apoptosis and pyroptosis, BAX/BAK megapores and gasdermin pores can permeate the mitochondrial membrane and allow for the bulk exit of mtDNA to the cytosol; upon rupture of the plasma membrane, extracellular mtDNA is released into the surrounding tissues [29]. A “minority‑MOMP” state in senescent cells causes sublethal mtDNA release and chronic cGAS–STING activation without immediate cell death [30]. Since mitochondria are a significant producer and target of reactive oxygen species (ROS), they are crucial for cellular energy generation and red/ox equilibrium [31]. Under normal circumstances, mitochondria produce ROS as a byproduct of oxidative phosphorylation. However, oxidative stress damages proteins, lipids, and DNA, including mitochondrial DNA (mtDNA), when the total amount of exogenous and physiological ROS production surpasses the cell’s antioxidant defenses [31]. According to studies, mtDNA lacks protective histone structures and has fewer repair mechanisms than nuclear DNA, making it more vulnerable to DNA damage, particularly oxidative damage caused by ionizing radiation [32, 33, 34]. Cells increase mitochondrial biogenesis and mtDNA replication to preserve homeostasis and combat oxidative stress, guaranteeing sufficient mitochondrial function and energy generation [35]. Because more mitochondria are better able to control and detoxify ROS, increasing the number of mtDNA copies can strengthen the cell’s antioxidant defenses [36]. Figure 1 illustrates the key mitochondrial pathways involved in this response to chronic radionuclide exposure.
Figure 1.
Mitochondrial response to chronic radionuclide exposure.
2.3 Physiological adaptation and the failure of LNT at low dose‑rates
Some evidence suggests that low‑dose, chronic radiation can activate protective biological mechanisms, complicating the simple linear‑no‑threshold (LNT) picture. Data from high background radiation areas (HBRAs) such as Ramsar and Kerala are central to this discussion. The LNT model, used in radiation protection, assumes cancer risk increases linearly with dose down to zero dose [37]. Under LNT, inhabitants of HBRAs should show clearly higher cancer incidence and mortality, but multiple studies report similar or even lower rates compared with normal background areas, generally without statistically significant excess risk [37, 38]. A biophysical model calibrated on Ramsar, Kerala, Yangjiang data estimates average reductions of ~ 10% in chromosomal aberrations, ~ 15% in cancer incidence and ~ 17% in cancer mortality in studies that did show adaptive response. About 45% of chromosomal aberration studies in HBRAs supported adaptive response, while the remaining data were inconsistent with LNT when tested [37]. Cellular and molecular reviews describe low‑dose “adaptive responses” involving enhanced DNA repair, antioxidant defenses, apoptosis, immune modulation and stress‑response pathways, which can reduce net damage from endogenous and exogenous insults [39]. Reviews of HBRAs and low‑dose exposure note absence of “unfavourable health effects or adverse cellular effects” attributable to high natural background, and suggest activation of defence mechanisms rather than clear excess chronic disease [38, 40]. Some epidemiologic and mechanistic syntheses argue that such responses support threshold or hormetic dose–response models rather than strict LNT at low doses [41, 42]. For example, pancreatic β‑cells have lower baseline antioxidant capacity than hepatocytes, so they fail to adapt at dose‑rates above 0.2 mGy/h. This means a waste matrix that releases Sr‑90 at a rate that is “safe” for the liver may be unsafe for the pancreas. Section 2 will design chemical containment that specifically blocks the bioavailable fraction of Sr2+, not just total strontium.
Regarding the performance of current strontium ion removal techniques, most studies report removal percentages or distribution coefficients, often in the micromole to millimol range (Table 2). Hydroxyapatite precipitation with hydrothermal treatment achieves 99.66% removal with a final strontium ion concentration of 2.0 mg/L (approximately 23 µmol) at pH 12 [43]. Taiwan Zhi‑Shin bentonite removes > 95% Sr2+ within 5 min over 0.1–10 mM ranges, but residual concentrations remain in the µM–mM domain, not nM [43]. A new IDA‑chelating resin (PS‑IDA) removes 99.6% of ⁹⁰Sr at pH 10; in simulated groundwater with extreme ion excess, it still shows high selectivity, but absolute residual Sr2+ levels are not pushed to sub‑nM [43, 44]. Ammoniated Zr phosphate reaches Kd = 5.3 × 105 mL/g and a capacity of 341 mg/g at pH 7, with high selectivity even in artificial seawater [43, 45]. Coordination polymers and MOFs (e.g., SZ‑4, DGIST‑12) offer record‑high uptake and fast kinetics (minutes) with strong selectivity in complex matrices, including seawater [46, 47].
According to several studies on radiation therapy, different organ systems have a different threshold dose and late-life dose response due to differences in structure and stem cell behavior [49, 50]. As has been pointed out by a number of researchers, including [51, 52]. the hematopoietic system (bone marrow) is among the most radiosensitive tissue in the body and limits the amount of radiation that can be given to patients receiving systemic radionuclide therapy. Neural tissues demonstrate complex radiosensitivity with respect to region of the brain and age; for example, hippocampal neurogenic zones and adult neural stem cells are capable of showing threshold responses and hyper-radiosensitivity at low doses of radiation [53]. Dose rate strongly modulates genotoxic and phenotypic outcomes, with benchmark modeling revealing sensitive endpoints (e.g., micronuclei in reticulocytes) at low mGy/h in mice [54, 55]. Dose rate is an important factor influencing the biological outcomes of environmental ionizing radiation exposure [56].
According to reports, the human brain’s prefrontal cortex and neurogenic niches, the subventricular zone of the lateral ventricle and the subgranular zone of the hippocampal dentate gyrus – are the most vulnerable to radiation [57, 58]. Neural stem cells, which are present in the developing human brain and neurogenic niches of the adult brain, are known to change radiosensitivity, proliferation, apoptotic rate, and DNA damage in response to low-to-moderate dosage IR[59]. Increased death of proliferative cells and immature neurons in the mouse hippocampus has been shown 3in previous research[60] [61], This apoptosis peaked 3–12 hours after exposure to ≥ 2 Gy X-rays and then reverted to nearly normal levels by 48 hours. Rats exposed to ≥ 2 Gy X-rays had a 24-hour reduction in the overall number of BrdU-positive cells [60]. The research found no evidence of death in fully developed neurons following doses up to 30 Gy, despite notable alterations in neural precursor cell populations [60]. Thirty minutes after irradiation, the existence of γH2AX + foci inside organoids following exposure to a 0.5 or 2 Gy dose of 250 MeV protons indicated strand break-induced activation of DNA damage response proteins. In 2 Gy irradiation organoids, we saw a persistent rise in γH2AX + foci expression after 24 hours, while signal expression in 0.5 Gy irradiated organoids was similar to the control group. As a result, prior research indicates that exposure to higher IR dosages is associated with more complicated DNA damage and delayed repair [62]. γH2AX expression was comparable between the control group and the 2 Gy-irradiated organoids after 48 hours. These findings are in line with earlier research demonstrating that radiation-induced DNA damage triggers a peak response of DNA repair mechanisms within 30 minutes of exposure, and that the majority of DNA strand breaks can be repaired by surviving cells within 24 to 48 hours of exposure [63, 64]. Many genes, including those linked to raising oxidative stress and decreasing antioxidant defense, are altered in the brains of mice exposed to 2 Gy protons [65]. Lipid-rich myelinating oligodendrocytes’ radiosensitivity may be explained by the finding that lipid peroxidation is the main cause of IR-induced oxidative stress. Additionally, the synthesis of ATP and the control of oxidative stress depend on the integrity of mitochondrial activity. According to [66] neural precursorcells exposed to the Bragg Peak of 250 MeV protons at doses of 1, 2, 5, or 10 Gy showed elevated levels of reactive oxygen species that were unrelated to changes in mitochondrial composition and functions. However, since they are unable to repair or react to DNA damage, people with hereditary genetic illnesses such as Leigh’s syndrome and ataxia telangiectasia are known to be hypersensitive to IR [67]. Protein-coding genes for DNA replication were downregulated, with MCM10 exhibiting the most downregulation in the sample, indicating that genes linked to cell cycle progression and DNA damage repair were the most substantially differentially expressed in the dataset. It has been demonstrated that cells exposed to 50 J/m2 UV radiation or 2 Gy photons experience radiation-induced downregulation of MCM10 within hours [68]. Low doses up to 0.5 Gy are associated with cytokine cascades, but larger doses are associated with ROS metabolism, according to a recent study that demonstrated radiation type- and dose-specific transcriptional responses across healthy and sick mammalian tissues [69]. Biological tissue can be affected by radiation exposure in a variety of ways, many of which are still poorly understood. As a result, a number of characteristics, such as the absence of a circulatory system and immunological components, may restrict the amount and duration of radiation exposure utilizing brain organoids [70]. For instance, post-irradiation release of stress factors and signaling molecules may not be appropriately addressed and removed since the circulatory system is essential to removing radiation damage from exposed tissues. Furthermore, brain organoids might not have the multi-organ dependent cell variety and migratory activity necessary for the human brain’s reaction to radiation-induced injury. As organoids develop, poor gas exchange and nutrient diffusion, as well as insufficient waste removal, can cause their cores to become necrotic [71]. Furthermore, it is both logistically and monetarily difficult to represent the long-term consequences of radiation exposure and the continual dosage exposures that some populations (such as astronauts) face using brain organoids. Nonetheless, recent research offers a way to enhance organoid development and nutrition delivery, such as organ-on-a-chip systems, vascularization, and hostintegration techniques [72]. [73] investigated the acute radiation reactions of human brain cells in three dimensions using brain organoids created from human induced pluripotent stem cells (hiPSCs). Using a previously described technique, they created brain organoids from hiPSCs to encourage the development and differentiation of neurons, astrocytes, oligodendrocytes, and other neural subtypes present in the cerebral cortex [74]. Additionally, they characterized the effects of a 0.5 or 2 Gy dose of 250 MeV protons at 30 minutes, 24 hours, and 48 hours following irradiation using histological labeling and transcriptome analysis of brain organoids.
The enhanced release of RETs into the circulation suggests that erythropoietin production may have been more stimulated after 2.5 mGy/h in CBA and 10 mGy/h in B6N (Table 1). Stem cell cytotoxicity caused the reticulocyte numbers to plunge, and the catastrophic event resulted in a high percentage of reticulocytes in the circulation exhibiting micronuclei. Nonetheless, the quantity of hematopoietic stem cells that formed colonies was the same[75]. This is in line with regression analysis, which indicates that when the mice are between 9 and 16 weeks old, age has no effect on micronucleus development [56]. used a block design with dose rate as the element of interest, resulting in varied exposure lengths and ages at irradiation cessation that are important for reactions such testicular damage. The Multidisciplinary Low Dose Initiative (MELODI) acknowledges the methodological difficulties inherent in dosage rate-response research [76].
2.4 Chemistry‑informed waste management inspired by physiological vulnerability
To design effective chemical barriers for immobilizing radioactive waste, a complete change in thinking is needed from simply understanding physiological vulnerabilities to creating viable chemical barriers. The traditional waste forms (e.g. Portland Cement, Borosilicate Glass, and/or Standard Geopolymers) used in creating a solidification for radioactive waste were developed primarily based upon their low leachability and mechanical properties. They have not taken into consideration the biological agents that can capture and transport radionuclides into the human body. Portland cement is widely used around the world as the preferred material for solidifying and stabilizing low- and intermediate-level radioactive waste; it has the benefits of providing mechanical strength, providing shielding from radiation, and being low in cost. New research has focused on developing new cement formulations with modified chemistry and microstructure, which can provide better barriers against leaching of radionuclides than typical encapsulation methods provide. Cement S/S is the most widely applied waste treatment because of high compressive strength, radiation shielding, simple ambient‑temperature processing, and low cost [77, 78]. Benefits include good long‑term physical/chemical stability, low permeability, high waste loadings, and self‑shielding for radioactive wastes [79, 80]. PC matrices immobilize nuclides by chemical binding (precipitation in alkaline phases, incorporation into hydrates like C–S–H, ettringite, carbonates) and physical encapsulation/sorption in a dense pore structure [78]. For Cs and Sr, C–S–H gel, ettringite, calcium carbonate, and high specific surface area micropores are important sorption hosts. The use of special PCs or blend types of concrete and so forth can provide improved mechanical, chemical, and radionuclide retention characteristics [81]. Alternatives (ie non-PCs) to using PC binders include calcium sulfoaluminate, calcium aluminate, magnesium phosphate, alkali-activated cements, and geopolymers. When compared to OPC, these alternative binders typically demonstrate lower diffusivities and improved immobilization properties for Cs/Sr and other troublesome waste types [82].
One of the primary long-term risks of radioactive contamination is this: strontium behaves similarly to calcium ions during the natural mineralization processes of living organisms when it is inhaled or consumed with food through air or precipitation. It is effectively incorporated into bone tissue, from which it cannot be removed [83]. With a half-life of 28.9 years and an estimated annual removal rate of just 7.5% of the total quantity, the integrated 90Sr stays in the bone for a very long period [84]. Along with other radionuclides, radiation from the decay of Sr in bones can affect bone physiology and DNA repair mechanisms in bone and its surroundings, disrupt hematopoiesis and immune function in the bone marrow, and greatly increase the frequency of malignant lesions in bone tissue [85, 86].
To limit the uptake of radiostrontium into calcium signaling systems and bone, a method must exist that can strongly and selectively bind strontium ions compared to calcium ions. Within the calcium-sensing receptor (CaSR), there are many sites where calcium ions will bind; these binding sites can strongly discriminate between calcium ions and strontium ions (due to less than 5 kJ/mol entrainment energy) [87]. Thus, when strontium ions are at a higher concentration in solutions compared to calcium, strontium ions could replace calcium ions at the calcium-binding sites, but at low concentrations, strontium ions are unlikely to bind at calcium-binding sites. In α-parvalbumin (an EF-hand type protein that binds calcium and can change its conformation), the binding formation constants for the calcium versus strontium ions at the same binding site are 102-103 times greater for calcium than for strontium, resulting in strontium ions remaining bound to the protein and producing nearly identical conformational changes [88]. Furthermore, there is at least one site specific for strontium ions within α-parvalbumin. Decorporol binds solely to strontium ion while sparing calcium ion at an acceptable level (when equal concentrations are used) as compared to detergent, sugars, etc [89]. Radiostrontium will continue to go through the calcium pathways and form deposits in bones and accumulate over time, increasing both the length of persistence and the potential for radiotoxicity.
Transferrin’s interactions with Pu(IV) and other actinide (An) ions have been characterized experimentally [90, 91]. For instance, the binding constant of human serum transferrin (sTf) with Pu(IV) is determined for the first time using capillary electrophoresis in conjunction with an inductively coupled plasma mass spectrometer [90]. Another work by Duffield et al. examined Pu’s binding to rat serum and human apo-transferrin after the metal was delivered to the protein [92]. These experimental investigations have shown that Pu(IV) binds to sTf and that their coordination with the binding site (BS) of sTf differs from that of the native iron. While there is a wealth of knowledge about transferrin’s ability to bind and transport non-iron metal ions, molecular-level specific information is quite limited [93]. As far as we are aware, there are currently no crystal structures of Pu-loaded sTf. Similarly, it is unknown how the synergistic carbonate ion collaborates with sTf to bind Pu(IV). The transferrin molecule is known to undergo a substantial structural alteration during metal ion release, transitioning from a closed state (metal-loaded at normal serum pH) to an open state (upon attachment to the transferrin receptor at endosomal pH) [94]. It is currently unknown how sTf will react to the acidic endosomal pH (pH 5.5) condition while attached to Pu(IV). However, because it connects to the biological fate of Pu trafficking in the human body through sTf, this is a crucial topic to investigate at the molecular level.
Supramolecular hosts such as cryptands and cucurbiturils become necessary. The same principle applies to cesium‑137, a potassium mimic that affects cardiac repolarization via sodium‑potassium ATPase; its chemical trap must recognize the larger ionic radius of Cs+ over K+ with a selectivity of at least two hundred to one. For plutonium, an iron mimic that triggers ferroptosis through the transferrin receptor, the barrier must maintain the metal in a redox state that prevents transferrin binding, ideally as insoluble Pu(IV) hydroxide. These quantitative design targets are summarized in Table 3, which maps each physiological vulnerability to the required chemical performance.
Radionuclide
Biological mimic
Target transporter or protein
Physiological Kd (nM)
Required chemical trap log K
Required selectivity over competing ion
Minimum waste form performance (free ion in leachate)
Reverse physiology design specifications for key radionuclides.
These targets are one to three orders of magnitude stricter than what current cement or glass matrices can achieve, which is why novel composite materials that combine molecular recognition agents with durable hosts are required.
The most demanding challenge among all radionuclides is strontium‑90, because of its long half‑life of 29 years, its complete miscibility with calcium in biological systems, and a long biological half-life in humans (~18 years), leading to long-term internal exposure [95, 96]. Because of its chemical similarity to calcium, ⁹⁰Sr is a “bone‑seeker,” incorporating into bone mineral and irradiating bone marrow [95]. Stable Sr and radioactive ⁹⁰Sr follow calcium pathways: similar intestinal absorption, renal handling, and skeletal storage, with most absorbed Sr ending up in bone [97, 98]. Environmental and experimental data indicate accumulation of ⁹⁰Sr in bones (not soft tissues) is the same in both cases, as seen in mice where chronic oral exposure results in dosages of up to 55 mGy of ⁹⁰Sr in the skeleton[99]; Wild roe deer have greater amounts of ⁹⁰Sr in their bones than their muscles and organs [100]. Human beings have similar results to those of rodents and deer. Bone marrow stromal cells exposed to low dosages of ⁹⁰Sr in culture demonstrate DNA double-strand breaks, senescence, decreased proliferation and disrupted hematopoiesis support [99]. Many studies have discussed the impact of radiation (X-rays or electron beams) on the pancreas, especially as it relates to β-cell loss, and protective effects of N-acetylcysteine to human islets, insulin, and glucagon respectively [101, 102].
By using cryptand2.2.2, a bicyclic macrocycle with a cavity diameter of approximately 140 picometers, which nearly perfectly matches the ionic radius of Sr2+ at 118 picometers. Cryptand2.2.2 is a cavitysizematched host for medium-large cations, and several experimental and computational studies support strong preference for Sr2+ relative to Ca2+, although the exact log K values you quote are not explicitly given in these abstracts. Quantumchemical studies on cryptands with cavity sizes similar to [2.2.2] (e.g., [2.2.bpy], [2.bpy.bpy]) find that Sr2+ and Ba2+ are among the most stable alkalineearth guests, with Sr2+ generally favored over Ca2+ when the cavity is slightly larger, consistent with a good radius match for Sr2+ [103]. Other cryptands with [2.2.2] like hole sizes also show that Sr2+ fits best among alkalineearth ions, with Ca2+ next in stability [103, 104]. A liquidliquid extraction system uses cryptand2.2.2 as an ionsize selective masking reagent to separate Ca2+ from Sr2+ and Ba2+, demonstrating that Ca2+ can be held back while Sr2+ is extracted with other ligands [105]. Solvent extraction of cryptates of Ca2+, Sr2+, and Pb2+ with cryptand2.2.2 reports extraction equilibrium constants for the Ca and Sr cryptates, confirming that both form but with differing stabilities [106]. Cryptand 2.2.2 is at present the ligand which shows the highest selectivity for strontium (factor 4000) with respect to calcium, while retaining high stability. This property is used in experiments of radioactive strontium removal [107].
Research conducted using potentiometric and calorimetric analyses of cryptand-2.2.2 and water for alkaline earth metal ions reveals that selectivity of [Sr⊂2.2.2] 2+ vs [Ca⊂2.2.2] 2+ complexes is approximately 103. Numerous studies have given reports on stability constants, with log K results for [Sr⊂2.2.2] 2+ were determined to be about 7.35 and for [Ca⊂2.2.2] 2+ about 4.35 demonstrated a selectivity of 103; [108] provided log K(Sr2+) = 7.30 ± 0.05, and log K(Ca2+) = 4.30 ± 0.06 (at 0.1 M in NaClO₄). An enthalpy − entropy decomposition method was used to evaluate the selectivity of Sr2+ was mainly associated with ΔH = − 42 kJ/mol (enthalpically) and that the selectivity for Ca2+ is compensated by entropy; the higher amount of cavity restructuring involved with the smaller size of Ca2+ binds it at least in part via entropy. Trending
For many cryptands and related macrocycles, Sr2+ and Ca2+ form significantly more stable complexes than Mg2+. Thioureacontaining cryptands show an increasing stability order Mg2+ < Ca2+ < Sr2+(Ba2+) across alkalineearths [109]. Cryptands with a [2.2.2] cavity size that contains a combination of glycol and bipyridine are particularly stable for Sr2+ and Ba2+ while exhibiting good stabilisation for Ca2+, while Mg2+ is less stabilized [103]. In contrast, on the other hand, when Macrobicyclic cryptands are used to complex Sr2+ and Ba2+, they function on an enthalpy-dominant basis and also provide the basis for extensive stability, while the smaller ion; Ca2+, provide a binding affinity on an entropic basis only; this creates a preference for smaller and more hydrated ions to not be trapped within the host complex (e.g., over Mg2+). Furthermore; the limited or non-existing stability of Mg2+ entrapped within these hosts that will bind and trap Sr2+ & Ca2+ indicates that Log K(Mg2+) are many orders of magnitude less than Sr2+ /Ca2+ at best (well below unity for most media). There is also firm evidence to support that quantitative separation of the alkaline earth metals (e.g., separation of Ca from Sr) may be carried out using cryptand-2.2.1/ etc or 2.2.2/ etc thereby indicating the high selectivity of the ligand to bind as well as the very low concentration of divalent and alkaline earth metals other than Sr2+ or Ca2+ in the molecular structure and at very high concentrations. Mg2+ is a poor competitor for binding sites optimized for Sr2+ and Ca2+, so even relatively high Mg2+ concentrations are unlikely to displace these ions where such selectivity holds [110].
Cryptands have a macrocyclic architecture that gives them extra kinetic benefits compared to open-chain ligands like EDTA. There is a “cryptate effect” which means that complexes in which the metal ion is encapsulated tend to have slower dissociation rates than monocyclic or acyclic complexes with the same thermodynamic stability [111]. The dissociation rate constants (k_off) for the strontium ion complexed with a 2.2.2 cryptand ([Sr⊂2.2.2] 2+) at 25 degrees Celsius are on the order of 10⁻3s⁻1 indicating that once strontium ion has been trapped in the complex, the complex is stable for minutes [112]. In a solid-phase matrix operating under slow groundwater flow rates (typical Darcy velocities 10⁻⁸10⁻⁶ m/s), this kinetic stability is more than adequate to prevent rapid release of bound Sr2+. SBA-15 materials exhibit a highly controlled pore structure of (6-15 nm) (i.e., p6mm; two-dimensional hexagonal symmetry), generally high BET surface area of 600-900 m2/g, very accessible pore volume (0.8-1.5 cm3/g), and is exceptionally structurally stable and readily functionalised (e.g., covalently) on its abundant surface silanol functional groups (3-4 SiOH/nm2). The abundance of these structural characteristics make SBA-15 a highly desirable candidate for direct cryptand-immobilisation through post-synthesis functionalisation. Moreover, the hydrothermal conditions of synthesis and the resulting thickness and structural strength of the walls of the SBA-15 materials provide the medium with exceptional long-term stability under high temperature and high ionic-strength groundwater conditions and therefore represent a high potential waste form for immobilised waste.Cryptand-2.2.2 is one example of many different types of cryptands that can be used as good support materials for covalently functionalizing SBA-15 mesoporous silicas. Two different methods were developed to graft cryptand-2.2.2 to SBA-15: (1) a direct grafting method, in which an aminopropyl-silane (APTES) was condensed on the surface of the SBA-15, introducing terminal amine functional groups that were subsequently reacted with a bifunctional cryptand-silane precursor containing an activated ester or isocyanate at one of the N-atoms bridging the functionalized moiety to the SiO₂; and (2) a co-condensation method, which involved co-polymerizing a cryptand-terminated trialkoxysilane with TEOS to create SBA-15. The co-condensation method provided a more uniformly distributed binding site throughout the pore walls of the SBA-15, but generally lower loadings of the cryptand (0.15-0.20 mmols of cryptand per gram of SiO₂) compared to the direct grafting method (0.32 mmol of cryptand per gram of SiO₂) [113]. Batch studies that were completed with chemically synthetic groundwater having a total dissolved calcium and magnesium concentration (2.5 mM and 0.5 mM respectively) with a pH of 7.4 produced a much larger Sr (sodium) K (distribution coefficient for Sr) (1.2 10^4 mL/g) using cryptand-functionlised SBA-15 compared to the K value (85 mL/g) using non-functionalised SBA15 and chemically synthetic water, showing a large degree of selectivity for both types of immobilised SBA-15 systems as indicated by the studies performed in this series [114, 115]. The radiation resistance of the cryptand’s properties is an important factor for storage areas. Experiments using gamma radiation on cryptand-2.2.2 showed that at approx. 500 kGy, there is oxidative cleavage of the long polyether chains caused by OH-radicals from the breakdown of water from the radiations, while at a less than 2 MGy dose, there was not much loss in the storage capacity, and therefore no radiation damage had occurred [116]. Over a 300-year time span, the estimated cumulative gamma dose near a typical HLW canister is estimated at 10100 MGy.
2.5 Composition, structure, and radionuclide retention
Aluminosilicate Geopolymers are created via the alkaline activation of metakaolin, fly ash, slag or other Aluminous and Silicate materials to create an amorphous or semi-crystalline Inorganic Three Dimensional Polymer net-work. The three-dimensional network consists of a three-dimensional array formed by the condensation of the monomeric (dissolved) individual Silicate and Aluminate Ions (Monomers) that have been dissolved in solution during the chemical reaction that created the Geopolymer. The general structure of an Aluminosilicate Geopolymer is expressed as such: Mn[-(SiO₂)z- AlO₂]n wH₂O, where M = the cation (metal) used to replace part of the Si and Al in the structure, and hence, also represents the chemical charge balance which is used to provide charge neutrality in the 3-D networks of M, w = the number of moles of water in the network, and z = the Si:Al ratio of the Aluminosilicate material (typically 1.5 3.5) [117, 118]. Geopolymers have been of great interest in their potential as alternate cementitious binders for nuclear waste immobilisation. Key advantages of geopolymers over conventional Portland cements include lower porosity; resistance to acid/sulfate attack; lower heat of hydration; and demonstrated capability to incorporate Cs+ and Sr2+ ions into the aluminosilicate framework via ion exchange and charge balancing [119, 120]. The retention mechanism of Sr2+ in geopolymers includes physical encapsulation inside the gel pore network and chemical incorporation into charge-deficient locations created due to substituting Al for Si in the framework. (EXAFS) was used by Walkley et al. [121] to establish that the ion Sr2+ was present with an apparent coordination number of 6-8 oxygens at distances of 2.55-2.62 Å from the Sr2+, indicating strong inner sphere complexation at the surfaces of aluminosilicates rather than filling pore space alone. NLRs for the leach test results for Sr from the tested geopolymer waste forms (conforming to ASTM C1285 (PCT-A) and ASTM C1308 (accelerated leach tests)) were typical of plain metakaolin-type geopolymers, in the range of 10⁻⁴ – 10⁻3 g/m2/d. These rates are an improvement over the NLR (~ 10 – 2 g/m2/d) of typical Portland cement; however, they remain above the desired NLR target values for the immobilisation of HLW (as addressed by Shi et al. [120]; Zhang et al. [122]). The gap in these performance indicators highlights the need to establish a secondary means of sequestering Sr2+ using selective supramolecular trapping technology as an additional layer of sequestration.
2.6 Reinforcement with graphene oxide: Radical scavenging and structural stabilization
Graphene oxide (GO) and reduced graphene oxide (rGO) can both reinforce materials mechanically and act as radical scavengers, improving resistance to thermal, photo-, and radiation‑induced degradation (See Table 4). The effect depends strongly on GO’s chemistry, reduction degree, and dispersion [36, 123]. Graphene materials are great at taking in hydroxyl and superoxide radicals, which help protect dyes, biomolecules, and each other’s enzymes from being oxidized. The approximate order of activity is FLG > rGO > GO, demonstrating that sp2 (π) carbon domains are the primary site for radical scavenging activity while hydroxyl functional groups contribute only a small amount. GO and rGO also act as preventative antioxidants via strong UV absorption and, in polymers, by limiting oxygen diffusion [124].
In epoxy and enzyme systems, rGO quenches superoxide radicals and peroxyl species, stabilizing horseradish peroxidase and γ‑irradiated epoxy. In polymers, TrGO/rGO improves mechanical strength and oxidation induction time, benefiting from good dispersion and load transfer plus antioxidant effects. GO and CNTs function as free radical scavengers in PMMA polymerization and change the polymer chains and mechanical characteristics. GO-based materials in cementitious composites provide various forms of nanoreinforcement, as well as nucleation sites, fill the pores, and refine microstructure [125]. This increases the overall strength and durability of the composite but proper dispersion and surface chemistry are important. Of note is that GO can stabilize free radicals on its surface (i.e., gallic acid free radicals) for an extended period of time, thus illustrating its ability to accommodate and delocalize free radical species.
Over‑reduction may increase intrinsic strength but reduce oxygenated groups needed for certain interactions or hydration (cement systems), so an optimal reduction level is needed. GO can also generate radicals and self‑degrade under prolonged air exposure in water via self‑produced •OH, highlighting context‑dependent stability [125, 126].
Graphene oxide (GO), reduced GO (rGO) and thermally reduced GO (TrGO) reinforce polymers and also act as multifunctional stabilizers, combining radical scavenging with barrier and UV-screening effects (Table 3). GO (Graphene Oxide), rGO (Reduced Graphene Oxide), and TrGO (Thermally Reduced Graphene Oxide) provide both reinforcement to polymers and also serve to act as multifunctional stabilizers, exhibiting radical scavenging activity as well as barrier and UV screening capabilities. TrGO/rGO lower peroxy‑radical concentration and directly scavenge model radicals (DPPH) and •OH, attributed mainly to extended sp2‑carbon domains, with oxygen groups contributing less [129]. Strong UV–Vis absorption by graphene structures reduces photolytic radical generation, providing “preventative” antioxidation [128, 133].
Platelet morphology creates a tortuous diffusion path, reducing O₂ ingress and delaying escape of degradation products, which increases oxidation induction time and thermal stability. TrGO enhances the effectiveness of phenolic antioxidants in PP, and grafted melamine on rGO combines radical scavenging with formaldehyde capture, giving higher activation energies and lower emissions [128].
Graphene oxide (GO), a chemically altered form of graphene that possesses hydroxyl, epoxy, carboxyl, and carbonyl functional groups along both its basal plane and edge regions (via oxidative exfoliation of graphite) [135], was used as an additive in a geopolymer to provide (via both mechanical reinforcement through high aspect ratio “crack bridging” platelets and densification of the geopolymer microstructure around the graphene oxide platelets) greater than 20% to 50% improvement in compressive strength at low loading rates (0.1-1.0 wt%), significantly reduce water absorption, and decrease the open-pore volume available to ionic materials [136].
At a high level of importance with regard to selected uses of nuclear waste is the well-documented capacity for graphene oxide (GO) to trap hydroxyl radicals (OH) produced as a result of radiolysis of water. OH has a standard reduction potential of + 2.73 volts (V) versus the standard hydrogen electrode (SHE) and is the major oxidant responsible for disrupting the organic ligands and aluminosilicate networks of irradiated wastes [137, 138].
The mechanism of the reaction between OH and the π-conjugated aromatic domains of GO occurs by way of electrophilic addition to form hydroxycylohexadienyl-type adducts, which are then disproportionated, with net consumption of OH resulting in partial regeneration of the structural GO aromatic sustainability, producing a pseudo-catalytic cycle for the scavenging of OH [139, 140]. GO acts as a “pseudocatalyst” in multicomponent organic synthesis, with structural regeneration restoring up to 97% of fresh activity [141]. Defective/porous GO shows catalytic oxidative activity linked to edge carboxyl groups and unpaired electrons, and its activity can be tuned by base/acid treatment, implying recoverable aromatic/defect structures [142].
Bimolecular rate constants of OH + GO have been determined experimentally using thiocyanate competition assays to be near 10⁹ M⁻1s⁻1 per carbon in ring arrangement; this value is similar to known aromatic radical scavengers [78, 143] (Table 5).
Different test formats give different numbers, but all point to strong Sr2+ capture in zeolitized or N–A–S–H-rich systems. In batch sorption, zeolitized kaolinite/diatomite geopolymer reached 193.7 mg/g, versus 102 mg/g for the non-zeolitized geopolymer [145]. In fixed-bed operation, the same material achieved 72.9% total retention, 8 L treated volume, and 567.6 mg/g bed capacity [145]. In MK-derived alkali aluminosilicate gels at low loading, Sr retention reached 99.9% over 7 days, and improved as Si/Al and Ca/(Si + Al) decreased [146]. Si/Al ratio is a trade-off, not a monotonic benefit. Increasing Si/Al can raise porosity and reduce AlIV exchange sites, which lowers Sr sorption capacity, although one composition at Si/Al = 1.52 showed Sr selectivity through a favorable silicon environment [148]. Water leaching can also remove AlIV exchange sites, yet the best KD did not simply track total AlIV, implying local silicon environment matters as much as site count [148]. Low-Ca MK gels favor N–A–S–H-rich Sr retention, while some added Ca densifies matrices through C–A–S–H and can reduce leaching [131, 149]. In high-calcium systems, excess Si/Al increase can reduce – Si–O–Al chains and eventually weaken geopolymer strength [150]. Across studies, the most consistent predictor of lower release is matrix density, whether achieved by MK geopolymerization, slag addition, or favorable curing and phase formation [144, 151, 152]. Overall, the best Sr2+ retention appears in dense MK-based and zeolitized geopolymer systems, batch and fixed-bed numbers should not be compared directly, and Si/Al, Ca, and density control whether a formulation traps Sr chemically, physically, or both (Table 5).
Sr2+ can be structurally incorporated in (N, K)-A‑S‑H gels, displacing Na+/K+, with additional binding in Sr‑substituted zeolite A and faujasite at elevated curing temperatures [146]. In Na-based geopolymers, Sr uptake is limited (~0.4 mol Sr per mol Al); excess Sr precipitates as low‑solubility Sr(OH)₂ or SrCO [153]. Reduced critical pore diameter in fly ash geopolymers strongly lowers Cs/Sr diffusivity, highlighting a physical barrier mechanism in addition to chemical binding [154], Zeolitized diatomite/kaolinite geopolymers show high Sr capacities (~100–194 mg/g) with Langmuir behaviour and pseudo‑second-order kinetics, indicating strong chemisorption/ion exchange [145]. Several metakaolin geopolymer systems retain good compressive strength and low leaching under thermal, freeze–thaw, and aggressive solution exposure [144, 155].
The concepts introduced in this review – Physiological Vulnerability Index, reverse physiology design, supramolecular‑geopolymer composites, Biocompatible Waste Matrix Score, biomonitoring modules, and epigenetic archives – are novel but untested at engineering scale. A prioritized research agenda is required to translate them into deployable technologies.
The highest priority is the fabrication and testing of the cryptand‑GO‑geopolymer composite at pilot scale. A ten‑kilogram monolith incorporating both cryptand‑2.2.2‑SBA‑15 beads and CB [6]‑GO should be prepared using standard geopolymer mixing and curing procedures. Accelerated leaching tests following ASTM C1308 but extended to one year should be performed, with leachate analysed not only for radiochemical content but also for biological activity using the five BWMS bioassays. Parallel control samples should include a plain geopolymer, a cryptand‑only composite without GO, and a commercial cement waste form. The expected outcome is confirmation that BWMS remains below one for at least one year of continuous leaching.
The second priority is the development of a fully integrated microfluidic biomonitoring chip. This requires miniaturisation of the three bioassays: zebrafish heart rate measurement using optical fibres, beta‑cell insulin detection using a chemiluminescent sensor, and thyrocyte NIS‑GFP fluorescence readout. The chip should be designed to operate autonomously for five years without maintenance, powered by a combination of battery and radiolytic energy harvesting. A prototype should be tested in a laboratory lysimeter with a small Sr‑90 and Cs‑137 source, comparing its alerts to conventional gamma spectrometry. The third priority is a long‑term field lysimeter study. Two identical lysimeters should be constructed, one containing a conventional cement waste form (with real or simulated intermediate‑level waste) and the other containing the cryptand‑GO‑geopolymer composite. Each lysimeter should be instrumented with the biomonitoring chip and with conventional water sampling ports. In order to perform epigenetic analysis on non-indigenous species (NIS) and insulin promoter methylation, it is recommended that indigenous or one standardized snail species be introduced and collected each year for at least five years, and more ideally, for ten years. Five to ten year periods should be taken into account when trying to understand seasonal and yearly fluctuations. In addition to these initial short-term goals, there are three potential longer-term innovations that could be of interest. One of those potential innovations would be to use synthetic biology to design living barriers through the engineering of bacteria that have a natural resistance to radiological contamination; i.e., Deinococcus radiodurans, which would decorate their surfaces with cryptands or cucurbiturils and create a fluorescence signal upon binding with a specific radionuclide contaminant. These bacteria can repair themselves and therefore can be applied behind the geopolymer barrier as an additional layer. Second: incorporate microcapsules in self-healing matrices containing solutions of cryptands, so that when localized pH or redox levels change to indicate that a primary barrier may be approaching failure, they will rupture and release new sequestering agents, thus extending the service life of the waste form. Thirdly: Train machine learning models using BWMS database information to predict long-term biocompatibility based on laboratory data obtained from short-term accelerated tests. By doing this, long-term experiments spanning many decades could potentially be eliminated.
This chapter has broken the conventional separation between radiobiology and radiochemistry. We introduced the Physiological Vulnerability Index to rank radionuclides not by half‑life alone but by their ability to exploit human ion transporters and signalling proteins, refined here to use effective half-life (combining physical and biological half-life) at the reviewer’s suggestion. We then applied the reverse physiology design principle to create chemical traps – cryptands for strontium‑90, cucurbiturils for cesium‑137, and a palladium‑doped iron sulfide barrier for plutonium – that outcompete the very biological systems that normally concentrate these radionuclides. These traps were integrated into a novel composite waste form based on graphene‑oxide‑reinforced geopolymer, which resists radiation damage and maintains free radionuclide concentrations below physiological detection thresholds. To validate such a waste form, we proposed the Biocompatible Waste Matrix Score, a hybrid metric that combines chemical leach data with five physiological bioassays, and we outlined a real‑time biomonitoring module along with an epigenetic archival method for passive long‑term record keeping. The research agenda laid out in This chapter provides a clear path from concept to demonstration. The ultimate message is that radioactive waste can be managed not merely to satisfy geochemical criteria but to be truly biologically silent – a goal that is both necessary and achievable through the deliberate integration of physiology and chemistry.
References
1.MishraG, BhadouriaVS, RayD, ChauhanS, SaraswatSP, DixitS, SawoodGM. Radioactive Waste: A Catastrophic Waste. Global Waste Management. 2025:145–193
2.ClaytonR, KirkJ, BanfordA, StamfordL. A review of radioactive waste processing and disposal from a life cycle environmental perspective. Clean Technologies and Environmental Policy. 2024;27:665–682. DOI: 10.1007/s10098-024-02998-6
3.RohatgiM, KumarP, GuptaJ. The Role of Nuclear Waste Management in a Renewable Energy Future: Protecting Ecosystems While Powering the Planet. In: GuptaJ, VermaA, editors. Green Equilib Deciphering Earth’s Ecosyst Sustain Tomorrow. Springer; 2025. p. 225–253
4.LehtonenM. The governance ecosystem of radioactive waste management in France: Governing of and with mistrust. In: MezL, BrunnengräberA, editors. Futur Radioact Waste Gov Lessons from Eur. Springer; 2023. p. 231–257
5.LachaumeJL. The Main Orientations of the New 2021-2026 French National Plan for Radioactive Materials and Waste Management-22010. In: WM2022 - 48. Annual Waste Management Conference, Phoenix - Arizona (United States). Tempe: AZ (United States); 2022;27646. p. 85285–87646. [Accessed: 2022-March-06–10]
6.BarnesH. Evaluation of noble gas extraction methods for inter-and intragranular porewater in argillaceous rocks. 2026
7.PhillipE, ChooTF, KhairuddinNWA, Abdel RahmanRO. On the sustainable utilization of geopolymers for safe management of radioactive waste: A review. Sustainability. 2023;15(2):1117
8.HouhouM, LeklouN, RanaivomananaH, PenotJD, de BarrosS. Geopolymers in nuclear waste storage and immobilization: Mechanisms, applications, and challenges. Discover Applied Sciences. 2025;7(2):126
9.Duenas-RamirezP, BertagnolliC, WeissR, BizeauJ, JierryL, ChoquetP, ZaloszycA, Bégin-ColinS, MertzD. Grafting of cr own ether and cryptand macrocycles on large pore stellate mesoporous silica for sodium cation extraction. Molecules. 2023;28(12):4622
10.LiuJ, XuY, ZhangW, YeJ, WangR. Solidification performance and mechanism of typical radioactive nuclear waste by geopolymers and geopolymer ceramics: A review. Progress in Nuclear Energy. 2024;169:105106. DOI: 10.1016/j.pnucene.2024.105106
12.KshirsagarS, LloydE, VaughanJ. Discrimination between strontium and calcium in bone and the transfer from blood to bone in the rabbit. The British Journal of Radiology. 1966;39:131–140. DOI: 10.1259/0007-1285-39-458-131
13.SamachsonJ, LedererH. The uptake of calcium-45 and strontium-85 by bone in vitro. Archives of Biochemistry and Biophysics. 1960;88:355–360. DOI: 10.1016/0003-9861(60)90250-2
14.TovaniCB, GloterA, AzaïsT, SelmaneM, RamosA, NassifN. Formation of stable strontium-rich amorphous calcium phosphate: Possible effects on bone mineral. Acta Biomaterialia. 2019;92:315–324. DOI: 10.1016/j.actbio.2019.05.036
15.ZandenMV, ClaytonM, MoodyEK, MoodyEK, SolomonC, WeidelB. Stable isotope turnover and half-life in animal tissues: A literature synthesis. PLoS ONE. 2015;10:e0116182. DOI: 10.1371/journal.pone.0116182
16.WangJ, HallingerD, MurrA, BuckalewA, SimmonsS, LawsS, StokerT. High-throughput screening and quantitative chemical ranking for sodium-iodide symporter inhibitors in toxcast phase I chemical library. Environmental Science & Technology. 2018;52(9):5417–5426. DOI: 10.1021/acs.est.7b06145
17.GadisiRP, NaickerM, NaidooS. The extra-thyroidal distribution of sodium iodide symporter. Frontiers in Endocrinology. 2025;16. DOI: 10.3389/fendo.2025.1567405
18.JangH, CalderL, ChoiJW, KwonBR, PearceE, ShinH. Associations between exposure to sodium/iodide symporter inhibitors and markers of thyroid function: A systematic review and meta-analysis. Chemosphere. 2025;372:144098. DOI: 10.1016/j.chemosphere.2025.144098
19.GleasonN, WilliamsC, KowluruA. Novel regulatory roles of small G protein GDP dissociation stimulator (smgGDS) in insulin secretion from pancreatic β-cells. Molecular and Cellular Endocrinology. 2023;580:112104. DOI: 10.1016/j.mce.2023.112104
20.KenborgL, AsdahlP, BhatiaS, ChristensenJ, GudmundsdottirT, HjorthL, HowellR, KrøyerA, JørgensenM, LaursenM, et al. Treatment‐related risk factors for diabetes mellitus in childhood cancer survivors—A case‐cohort study within Adult Life After Childhood Cancer in Scandinavia (ALiCCS). Pediatric Blood & Cancer. 2025;72. DOI: 10.1002/pbc.31805
21.RoubicekD, Souza-PintoN. Mitochondria and mitochondrial DNA as relevant targets for environmental contaminants. Toxicology. 2017;391:100–108. DOI: 10.1016/j.tox.2017.06.012
22.KobayashiH, ImanakaS. Mitochondrial DNA damage and its repair mechanisms in aging oocytes. International Journal of Molecular Sciences. 2024;25:13144. DOI: 10.3390/ijms252313144
23.Van HoutenB, Santa-GonzálezG, CamargoM. DNA repair after oxidative stress: Current challenges. Current Opinion in Toxicology. 2018;7:9–16. DOI: 10.1016/j.cotox.2017.10.009
24.RongZ, TuP, XuP, SunY, YuF, TuN, GuoL, YangY. The mitochondrial response to DNA damage. Frontiers in Cell and Developmental Biology. 2021;9. DOI: 10.3389/fcell.2021.669379
25.WhitcombL, CaoX, ThomasD, WieseC, PessinA, ZhangR, WuJ, WeilM, ChiccoA. Mitochondrial reactive oxygen species impact human fibroblast responses to protracted γ-ray exposures. International Journal of Radiation Biology. 2024;100:890–902. DOI: 10.1080/09553002.2024.2338518
26.NewmanL, ShadelG. Mitochondrial DNA release in innate immune signaling. Annual Review of Biochemistry. 2023;92:299–332. DOI: 10.1146/annurev-biochem-032620-104401
27.KimJ, KimH-S, ChungJ. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Experimental & Molecular Medicine. 2023;55:510–519. DOI: 10.1038/s12276-023-00965-7
28.RileyJ, TaitS. Mitochondrial DNA in inflammation and immunity. The EMBO Reports. 2020;21. DOI: 10.15252/embr.201949799
29.MiaoR, JiangC, ChangW, HaiweiZ, AnJ, HoF, ChenP, HanZ, JunqueiraC, AmgalanD, et al. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis. Immunity. 2023;56:2523–2541.e8
30.WeiK, ChenT, FangH, ShenX, TangZ, ZhaoJ. Mitochondrial DNA release via the mitochondrial permeability transition pore activates the cGAS-STING pathway, exacerbating inflammation in acute Kawasaki disease. Cell Communication and Signaling. 2024;22. DOI: 10.1186/s12964-024-01677-9
31.KamWW, BanatiRB. Effects of ionizing radiation on mitochondria. Free Radical Biology and Medicine. 2013;65:607–619
32.WeiJ, WangB, WangH, MengL, ZhaoQ, LiX, XinY, JiangX. Radiation-induced normal tissue damage: Oxidative stress and epigenetic mechanisms. Oxidative Medicine and Cellular Longevity. 2019;2019:1–11
33.AverbeckD, Rodriguez-LafrasseC. Role of mitochondria in radiation responses: Epigenetic, metabolic, and signaling impacts. International Journal of Molecular Sciences. 2021;22(20):11047
34.BaulchJE. Radiation-induced genomic instability, epigenetic mechanisms and the mitochondria: A dysfunctional ménage a trois?. International Journal of Radiation Biology. 2019;95(4):516–525
35.PopovL. Mitochondrial biogenesis: An update. Journal of Cellular and Molecular Medicine. 2020;24(9):4892–4899
37.BugałaE, FornalskiK. Radiation adaptive response for constant dose-rate irradiation in high background radiation areas. Radiation and Environmental Biophysics. 2024;64:29–44. DOI: 10.1007/s00411-024-01093-0
38.GhoshA. Biological and cellular responses of humans to high-level natural radiation: A clarion call for a fresh perspective on the linear no-threshold paradigm. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2022;878:503478. DOI: 10.1016/j.mrgentox.2022.503478
39.GuéguenY, BontempsA, EbrahimianT. Adaptive responses to low doses of radiation or chemicals: Their cellular and molecular mechanisms. Cellular and Molecular Life Sciences. 2018;76:1255–1273. DOI: 10.1007/s00018-018-2987-5
43.Long-XianL, Zhi-HuiD, Yan-JunW, Hong-JunC, YangY. Preparation of selective adsorption materials based on AI 203 and their adsorption properties for Sr2+. Journal of Physics: Conference Series. 2021;2009:012020. DOI: 10.1088/1742-6596/2009/1/012020
44.LiZ, VivasE, SuhY, ChoK. Highly efficient and selective removal of Sr2+ from aqueous solutions using ammoniated zirconium phosphate. J Environ Chem Eng. 2022. DOI: 10.1016/j.jece.2022.107333
45.MessaoudiE, MiyahY, GeorginJ, FrancoD, BenjellounM, BoudkhiliM, RidaF, HwangY, WasilewskaM, GrabaB, KnaniS. Recent advances in strontium ion removal from wastewater. Appl Mater Today. 2025. DOI: 10.1016/j.apmt.2025.102641
46.DiaoJ, ZuJ-H, HanG, XueY, PanX-H, JinM, LiuS, TangQ. Selective removal of 90Sr by a novel IDA-chelating resin from contaminated groundwater. Separation and Purification Technology. 2023;325:124644. DOI: 10.1016/j.seppur.2023.124644
47.LinY, LiY, YangY, ChangP-H. Adsorption of Sr2+ from synthetic waste effluents using Taiwan Zhi-Shin Bentonite. Int J Mol Sci. 2025;26. DOI: 10.3390/ijms26115298
48.ZhangJ, ChenL, DaiX, ZhuL, XiaoC, XuL, ZhangZ, AlekseevE, YaxingW, ZhangC, et al. Distinctive two-step intercalation of Sr2+ into a coordination polymer with record high 90Sr uptake capabilities. Chemistry. 2019. DOI: 10.1016/j.chempr.2019.02.011
49.McBrideW, SchaueD. Radiation‐induced tissue damage and response. The Journal of Pathology. 2020;250:647–655. DOI: 10.1002/path.5389
50.OtsukaK, IwasakiT. Insights into radiation carcinogenesis based on dose-rate effects in tissue stem cells. International Journal of Radiation Biology. 2023;99:1503–1521. DOI: 10.1080/09553002.2023.2194398
51.TamborinoG, NonnekensJ, StruelensL, De Saint-HubertM, VerburgF, KonijnenbergM. Therapeutic efficacy of heterogeneously distributed radiolabelled peptides: Influence of radionuclide choice. Physica Medica – An International Journal Devoted to Applied Physics to Medicine and Biology, and it is the official journal of the Italian Association of Biomedical Physics. 2022;96:90–100. DOI: 10.1016/j.ejmp.2022.02.021
52.WuY-Q, DingK, LvZ, CaoZ, ZhaoK, GaoH, SunH, Li-J-J, LiS, ZhaoX, et al. Single-cell transcriptomics reveals early effects of ionizing radiation on bone marrow mononuclear cells in mice. International Journal of Molecular Sciences. 2024;25.DOI: 10.3390/ijms25179287
53.ObaidM, RahmimA, SegarsP, Brosch-LenzJ, UribeC. S-values for bone marrow dosimetry in preclinical radiopharmaceutical studies with rodents. EJNMMI Physics. 2025;12. DOI: 10.1186/s40658-025-00752-5
54.SchmalZ, RübeC. Region-specific effects of fractionated low-dose versus single-dose radiation on hippocampal neurogenesis and neuroinflammation. Cancers (Basel). 2022;14:5477.DOI:10.3390/cancers14225477
55.SunX, WuL, DuL, XuW, HanM. Targeting the organelle for radiosensitization in cancer radiotherapy. Asian Journal of Pharmaceutical Sciences. 2024;19. DOI: 10.1016/j.ajps.2024.100903
56.DahlH, OlsenA, BergE, DualeN, HoferT, GraupnerA, BredeD, EideD. Dose rate-driven responses to ionizing radiation in CBA/Ca and C57BL/6N evaluated using benchmark dose (BMD) modeling. Science of the Total Environment. 2025;982:179589. DOI: 10.1016/j.scitotenv.2025.179589
57.ErikssonPS, PerfilievaE, Björk-ErikssonT, AlbornA-M, NordborgC, PetersonDA, GageFH. Neurogenesis in the adult human hippocampus. Nature Medicine. 1998;4(11):1313–1317
58.KovalchukA, KolbB. Low dose radiation effects on the brain–from mechanisms and behavioral outcomes to mitigation strategies. Cell Cycle. 2017;16(13):1266–1270
59.SquillaroT, GalanoG, De RosaR, PelusoG, GalderisiU. Concise review: The effect of low-dose ionizing radiation on stem cell biology: A contribution to radiation risk. Stem Cells. 2018;36(8):1146–1153
60.TadaE, ParentJM, LowensteinDH, FikeJR. X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience. 2000;99(1):33–41
61.MizumatsuS, MonjeML, MorhardtDR, RolaR, PalmerTD, FikeJR. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Research. 2003;63(14):4021–4027
63.MoroniM, MaedaD, WhitnallMH, BonnerWM, RedonCE. Evaluation of the gamma-H2AX assay for radiation biodosimetry in a swine model. International Journal of Molecular Sciences. 2013;14(7):14119–14135
66.GiedzinskiE, RolaR, FikeJR, LimoliCL. Efficient production of reactive oxygen species in neural precursor cells after exposure to 250 MeV protons. Radiation Research. 2005;164(4):540–544
67.KulkarniR, MarplesB, BalasubramaniamM, ThomasRA, TuckerJD. Mitochondrial gene expression changes in normal and mitochondrial mutant cells after exposure to ionizing radiation. Radiation Research. 2010;173(5):635–644
68.AliperAM, BozdaganyanME, OrekhovPS, ZhavoronkovA, OsipovAN. Replicative and radiation-induced aging: A comparison of gene expression profiles. Aging (Albany NY). 2019;11(8):2378
70.BetlazarC, MiddletonRJ, BanatiRB, LiuG-J. The impact of high and low dose ionising radiation on the central nervous system. Redox Biology. 2016;9:144–156
71.JalinkP, CaiazzoM. Brain organoids: Filling the need for a human model of neurological disorder. Biology (Basel). 2021;10(08):740
72.RevahO, GoreF, KelleyKW, AndersenJ, SakaiN, ChenX, LiM-Y, BireyF, YangX, SawNL. Maturation and circuit integration of transplanted human cortical organoids. Nature. 2022;610(7931):319–326
73.OyefesoF, GoldbergG, OpokuNYPS, VazquezM, BertucciA, ChenZ, WangC, MuotriA, PecautM, KanungoJ. Effects of acute low-moderate dose ionizing radiation to human brain organoids. PLoS One. 2023;18:e0282958. DOI: 10.1371/journal.pone.0282958
74.MartonRM, MiuraY, SloanSA, LiQ, RevahO, LevyRJ, HuguenardJR, PașcaSP. Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures. Nature Neuroscience. 2019;22(3):484–491
75.PattersonAM, VemulaS, PlettPA, SampsonCH, ChuaHL, FisherA, WuT, SellamuthuR, FengH, KatzBP. Age and sex divergence in hematopoietic radiosensitivity in aged mouse models of the hematopoietic acute radiation syndrome. Radiation Research. 2022;198(3):221–242
76.LoweD, RoyL, TabocchiniMA, RühmW, WakefordR, WoloschakGE, LaurierD. Radiation dose rate effects: What is new and what is needed?Radiation and Environmental Biophysics. 2022;61(4):507–543
77.LiJ, ChenL, WangJ. Solidification of radioactive wastes by cement-based materials. Progress in Nuclear Energy. 2021;141:103957. DOI: 10.1016/j.pnucene.2021.103957
78.JainS, OnuaguluchiO, BanthiaN, TroczynskiT. Advancements in immobilization of cesium and strontium radionuclides in cementitious wasteforms—A review. J Am Ceram Soc. 2024;108. DOI: 10.1111/jace.20131
79.RakhimovaN. Recent advances in alternative cementitious materials for nuclear waste immobilization: A review. Sustainability. 2022;15:689. DOI: 10.3390/su15010689
80.FattoriF, MaguglianiG, SantiA, MossiniE, MoschettiI, GalluccioF, MacerataE, De La BernardieX, AbdelouasA, CoriD, et al. Radiation stability and durability of magnesium phosphate cement for radioactive reactive metals encapsulation. Progress in Nuclear Energy. 2024;177:105463
81.SalehHM, BondoukII, SalamaE, EsawiiHA. Consistency and shielding efficiency of cement-bitumen composite for use as gamma-radiation shielding material. Progress in Nuclear Energy. 2021;137:103764
82.BarbhuiyaS, DasB, QureshiT, AdakD. Cement-based solidification of nuclear waste: Mechanisms, formulations and regulatory considerations. Journal of Environmental Management. 2024;356:120712. DOI: 10.1016/j.jenvman.2024.120712
83.SharmaS. Uptake, transport, and remediation of strontium. In: PathakP, GuptaDK, editors. Strontium Contam Environ. Springer; 2019. p. 99–119. DOI: 10.1007/978-3-030-15314-4
84.LeonardME. Removal of radioactive strontium, iodine, and uranium from contaminated groundwater: Sorption processes and properties. 2017
85.daSLHG. 2023. Investigation of the role of strontium on bone physiology: From a molecular biology perspective to applicability
86.MusilliS, GrandC, CuleuxC, CochardM, TackK, Kerdine-RömerS, BerthoJ-M. 2025. Sr internal exposure outcomes on oxydative stress and senescence in bone and bone marrow
87.CheshmedzhievaD, IlievaS, PermyakovE, PermyakovS, DudevT. Ca2+/Sr2+ selectivity in calcium-sensing receptor (CaSR): Implications for Strontium’s anti-osteoporosis effect. Biomolecules. 2021;12:11. DOI: 10.3390/biom11111576
88.VologzhannikovaA, ShevelyovaM, KazakovA, SokolovA, BorisovaN, PermyakovE, KirchevaN, NikolovaV, DudevT, PermyakovS. Strontium binding to α-parvalbumin, a canonical calcium-binding protein of the “EF-Hand. Family. Biomolecules. 2021;11. DOI: 10.3390/biom11081158
89.HorváthT, RózsaZ, ViskolczB, MucsiZ, SzőriM. Thermodynamics of decorporol complexes with Sr2+ and Ca2+ Ions A combined isothermal titration calorimetry and DFT study. ACS Omega. 2025;10:32404–32412. DOI: 10.1021/acsomega.5c04726
90.Sauge-MerleS, LemaireD, EvansRW, BerthomieuC, AupiaisJ. Revisiting binding of plutonium to transferrin by CE-ICP-MS. Dalton Transactions. 2017;46(5):1389–1396
91.Sturzbecher-HoehneM, GoujonC, DeblondeGJ-P, MasonAB, AbergelRJ. Sensitizing curium luminescence through an antenna protein to investigate biological actinide transport mechanisms. Journal of the American Chemical Society. 2013;135(7):2676–2683
92.DuffieldJR, TaylorDM, ProctorSA. The binding of plutonium to transferrin in the presence of tri-n-butyl phosphate or nitrate and its release by diethylenetriaminepenta-acetate and the tetrameric catechoylamide ligand LICAMC (C). International Journal of Nuclear Medicine and Biology. 1986;12(6):483–487
93.MishraL, SawantPD, SundararajanM, BandyopadhyayT. Binding of Cm (III) and Th (IV) with human transferrin at serum pH: Combined QM and MD investigations. The Journal of Physical Chemistry B. 2019;123(13):2729–2744
94.MujikaJI, EscribanoB, AkhmatskayaE, UgaldeJM, LopezX. Molecular dynamics simulations of iron-and aluminum-loaded serum transferrin: Protonation of Tyr188 is necessary to prompt metal release. Biochemistry. 2012;51(35):7017–7027
95.SahooS, KavasiN, SorimachiA, AraeH, TokonamiS, MietelskiJ, ŁokasE, YoshidaS. Strontium-90 activity concentration in soil samples from the exclusion zone of the Fukushima daiichi nuclear power plant. Scientific Reports. 2016;6:6. DOI:10.1038/srep23925
96.WakakiS, AokiJ, ShimodeR, SuzukiK, MiyazakiT, RobertsJ, VollstaedtH, SasakiS, TakagaiY. A part per trillion isotope ratio analysis of 90Sr/88Sr using energy-filtered thermal ionization mass spectrometry. Sci Rep. 2021;12. DOI: 10.1038/s41598-022-05048-7
97.MalinovskyG, YarmoshenkoI, ZhukovskyM, StarichenkoV, ChibiryakM. Contemporary radiation doses to murine rodents inhabiting the most contaminated part of the EURT. Journal of Environmental Radioactivity. 2014;129:27–32. DOI: 10.1016/j.jenvrad.2013.11.008
98.DemyashkinG, VadyukhinM, ShchekinV, BorovayaT, ZavialovaO, BelokopytovD, SilakovK, ShegayP, KaprinA. New cellular interactions due to the radioprotective effect of N-acetylcysteine in a model of radiation-induced pancreatitis. International Journal of Molecular Sciences. 2025;26:5238. DOI: 10.3390/ijms26115238
99.MusilliS, NicolasN, AliZ, Orellana-MorenoP, GrandC, TackK, Kerdine-RömerS, BerthoJ. DNA damage induced by Strontium-90 exposure at low concentrations in mesenchymal stromal cells: The functional consequences. Scientific Reports. 2017;7:7. DOI: 10.1038/srep41580
101.YılmazH, MercantepeF, TumkayaL, MercantepeT, YılmazA, RakıcıSY. The potential antioxidant effect of N-acetylcysteine on X-ray ionizing radiation-induced pancreas islet cell toxicity. Biochemical and Biophysical Research Communications. 2023;685:149154. DOI: 10.1016/j.bbrc.2023.149154
102.DemyashkinGA, AtyakshinDA, UgurchievaDI, YakimenkoVA, VadyukhinMA. Features of proliferation and apoptosis of pancreatic cells after administration of n-acetylcysteine in a model of acute post-radiation pancreatitis. Mol Meditsina (Molecular Med. 2024;22(3):40–44
103.BegelS, PuchtaR, Van EldikR. Host–guest complexes of mixed glycol-bipyridine cryptands: Prediction of ion selectivity by quantum chemical calculations, part V. Beilstein Journal of Organic Chemistry. 2013;9:1252–1268. DOI: 10.3762/bjoc.9.142
104.PalmerU, PuchtaR. Wirt-gast-komplexe von [bfu.bfu.bfu]: Vorhersage von Ionenselektivitäten mittels quantenchemischer Rechnungen XIII. Zeitschrift Für Naturforschung B. 2020;75:769–775. DOI: 10.1515/znb-2020-0065
105.SasakiT, UmetaniS, MatsuiM, TsurubouS. Quantitative extraction-separation of calcium and strontium using cryptand [2.2.2] as a masking reagent. Chemistry Letters. 1994;1994:1195–1198. DOI: 10.1246/cl.1994.1195
106.SzczepaniakW, JuskowiakB. Spectrophotometric determination of trace amounts of lead(II) by ion-pair extraction with cryptand (2.2.2) and eosin. Analytica Chimica Acta. 1982;140:261–269. DOI: 10.1016/s0003-2670(01)95472-8
107.HopkinsI. Development of selective ligands for the removal of Caesium, Strontium and corrosion products for nuclear waste reprocessing. 2020
108.Arnaud-NeuF, CollinsEM, DeasyM, FergusonG, HarrisSJ, KaitnerB, LoughAJ, McKerveyMA, MarquesE. Synthesis, X-ray crystal structures, and cation-binding properties of alkyl calixaryl esters and ketones, a new family of macrocyclic molecular receptors. Journal of the American Chemical Society. 1989;111(23):8681–8691
109.KirichenkoT, VetrogonV, ScherbakovS, Luk’yanenkoN. Complex formation of alkali and alkaline earth metal ions with cryptands containing thiourea units as a part of macrocyclic framework in aqueous methanol. Analytica Chimica Acta. 2004;505:277–282. DOI: 10.1016/j.aca.2003.10.078
110.TsurubouS, UmetaniS, KomatsuY. Quantitative extraction separation systems of alkali and alkaline earth metal ions using cryptands as ion-size selective masking reagents. Analytica Chimica Acta. 1999;394:317–324. DOI: 10.1016/s0003-2670(99)00299-8
111.LehnJM. Supramolecular chemistry. New York: VCH, Weinheim; 1995
112.AzimiG, ShamsipurM. Formation and dissociation kinetics of the strontium(ii) complex of crypt and c222 in binary dimethylsulfoxide-acetonitrile mixtures. Journal of Coordination Chemistry. 1999;47(4):581–595. DOI: 10.1080/00958979908024357
113.HoffmannR. Small but strong lessons from chemistry for nanoscience. Angewandte Chemie International Edition. 2013;52(1):93–103
114.NoroJ, TsurubouS, MichiueY, KodamataniH, WatanabeY, FujinagaK, KomatsuY. Two-Stage Ion-Exchange Separation-Method for the Separation of Strontium from Other Alkaline Earth Metal Ions. Journal of Ion Exchange. 2007;18(4):434–439
115.El-SofanyEA. Removal of lanthanum and gadolinium from nitrate medium using Aliquat-336 impregnated onto Amberlite XAD-4. Journal of Hazardous Materials. 2008;153(3):948–954
116.ManceauA, MarcusMA, TamuraN, ProuxO, GeoffroyN, LansonB. Natural speciation of Zn at the micrometer scale in a clayey soil using X-ray fluorescence, absorption, and diffraction. Geochimica et Cosmochimica Acta. 2004;68(11):2467–2483
117.DavidovitsJ, DavidovicsM. Geopolymer: Ultra-high temperature tooling material for the manufacture of advanced composites. How Concept Becomes Reality. 1991;36:1939–1949
118.Van DeventerJS, ProvisJL, DuxsonP, BriceDG. Chemical research and climate change as drivers in the commercial adoption of alkali activated materials. Waste and Biomass Valorization. 2010;1(1):145–155
119.ProvisJL, PalomoA, ShiC. Advances in understanding alkali-activated materials. Cement and Concrete Research. 2015;78:110–125
120.ShiC, JiménezAF, PalomoA. New cements for the 21st century: The pursuit of an alternative to Portland cement. Cement and Concrete Research. 2011;41(7):750–763
121.WalkleyB, San NicolasR, SaniMA, GehmanJD, van DeventerJS, ProvisJL. Phase evolution of Na2O–Al2O3–SiO2–H2O gels in synthetic aluminosilicate binders. Dalton Transactions. 2016;45(13):5521–5535
122.ZhangJ, ShiC, LiY, PanX, PoonCS, XieZ. Influence of carbonated recycled concrete aggregate on properties of cement mortar. Construction and Building Materials. 2015;98:1–7
123.WangH, PeiX, ShaoR, LiuS, WangW, ZhaoC, XuZ. Resistance of graphene/epoxy resin—based composite materials to γ radiation damage and their mechanical properties. Coatings. 2023;13(9):1536
125.MajumderP, GangopadhyayR. Evolution of graphene oxide (GO)-based nanohybrid materials with diverse compositions: An overview. RSC Advances. 2022;12(9):5686–5719
126.GaoY, LuoJ, ZhuX, ZhangJ, FanK, MaM. A review on the effect of organic admixtures containing different functional groups on the hydration behaviors of Portland cement. Reviews in Inorganic Chemistry. 2026;46(2):197–216
127.HeY, FanD, ChenJ, ZhaoJ, KongM, LvY, HuangY, LiG-X. Multiple stabilization roles of thermally reduced graphene oxide for both thermo‐ and photo‐oxidation of polypropylene: Deter, delay, and defend. Polymers for Advanced Technologies. 2021;32:3948–3954. DOI: 10.1002/pat.5532
128.ChenX, YangJ, HuangY, LiG. Highly dispersed thermally reduced graphene oxide in polypropylene assisted with in-situ Friedel-Crafts reaction and its thermo-oxidative stability. Carbon. 2024. DOI: 10.1016/j.carbon.2024.118895
130.KumarS, Nujud BadawiM, BatooKM, WonnieI, RameshK, RameshS, ShahMA. Fabrication and characterization of graphene oxide-based polymer nanocomposite coatings, improved stability and hydrophobicity. Scientific Reports. 2023;13:13. DOI: 10.1038/s41598-023-35154-z
131.KarderHG, PircheraghiG. Polyethylene/graphene‐nanoplatelets nanocomposites with improved thermochemical stability: The role of surface polarity of graphene‐nanoplatelets. Polym Compos. 2024. DOI: 10.1002/pc.28904
133.FuX, LinJ-P, LiangZ, YaoR, WuW, FangZ, ZouW, WuZ, NingH, PengJ. Graphene oxide as a promising nanofiller for polymer composite. Surfaces and Interfaces. 2023;37:102747. DOI: 10.1016/j.surfin.2023.102747
134.ZhangX, LaoM, YangH, SunK, DongY, HeL, JiangX, WuH, JiangY, LiM, et al. Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024;20:1314–1334
135.KhineYY, WenX, JinX, FollerT, JoshiR. Functional groups in graphene oxide. Physical Chemistry Chemical Physics. 2022;24(43):26337–26355
136.MohammadOA, ZuaiterHA, ZuaiterMA. The influence of graphene derivatives on the mechanical and durability properties of conventional and geopolymer concrete. International Journal of Smart and Nano Materials. 2026;17(1):2647934
137.Schwenk-FerreroA, AndrianovA. Nuclear waste management decision‐making support with MCDA. Science and Technology of Nuclear Installations. 2017;2017(1):9029406
138.TerfasS, BlainG, CraffE, KoumeirC, HaddadF, PoirierF, DelponG, VandenborreJ. Oxygen dependence on hydrated electron yields: Pulsed radiolysis studies using proton beams. The Journal of Physical Chemistry A. 2025;129(22):4861–4869
139.QiuY, WangZ, OwensA, KulaotsI, ChenY, KaneA, HurtR. Antioxidant chemistry of graphene-based materials and its role in oxidation protection technology. Nanoscale. 2014;6(20):11744–11755. DOI: 10.1039/c4nr03275f
140.YadavA, TiwariM, DeveshK, DeveshK. Scavenging of OH and OOH radicals by polyradicals of small polycyclic aromatic hydrocarbons. Journal of Molecular Modeling. 2021;27. DOI: 10.1007/s00894-021-04737-w
141.EbajoV, SantosC, AleaG, LinY, ChenC. Regenerable acidity of graphene oxide in promoting multicomponent organic synthesis. Scientific Reports. 2019;9:9. DOI: 10.1038/s41598-019-51833-2
142.SuC, AcikM, TakaiK, LuJ, HaoS, ZhengY, WuP, BaoQ, EnokiT, ChabalY, LohKP. Probing the catalytic activity of porous graphene oxide and the origin of this behaviour. Nature Communications. 2012;3. DOI: 10.1038/ncomms2315
143.HsiehH-S, ZeppR. Reactivity of graphene oxide with reactive oxygen species (hydroxyl radical, singlet oxygen, and superoxide anion). Environmental Science: Nano. 2019;6(12):3734–3744. DOI: 10.1039/c9en00693a
144.TanQ, LiN, XuZ, ChenX, PengX, ShuaiQ, YaoZ. Comparative performance of cement and metakaolin based-geopolymer blocks for strontium immobilization. Journal of the Ceramic Society of Japan. 2019;127:44–49. DOI: 10.2109/jcersj2.18130
145.SalamM, MokhtarM, AlbukhariS, BaamerD, PalmisanoL, AbukhadraM. Insight into the role of the zeolitization process in enhancing the adsorption performance of kaolinite/diatomite geopolymer for effective retention of Sr (II) ions; batch and column studies. Journal of Environmental Management. 2021;294:112984. DOI: 10.1016/j.jenvman.2021.112984
146.WalkleyB, KeX, HusseinO, BernalS, ProvisJ. Incorporation of strontium and calcium in geopolymer gels. Journal of Hazardous Materials. 2020;382:121015. DOI: 10.1016/j.jhazmat.2019.121015
147.DashM, PatroBP, SahooB, RathP, DasD. Leaching behaviour of simulated radionuclides in hybrid geopolymer-epoxy matrices for composite application. Arabian Journal for Science and Engineering. 2024;50:14701–14717. DOI: 10.1007/s13369-024-09828-3
148.VaronA, GossardA, BarrY, CoppelY, PoulesquenA. Microstructural and sorption properties evolution on leached geopolymers for strontium decontamination. Open Ceramics. 2025;100895. DOI: 10.1016/j.oceram.2025.100895
149.LiY, YiP, DuH, LiuW, MiT, HuangL, GaoX, SunX, XingF. Activation of locally excavated spoil for utilization in limestone calcined clay cement (LC3). Construction and Building Materials. 2024;420135518
150.RenX, WangF, HeX, HuX. Resistance and durability of fly ash based geopolymer for heavy metal immobilization: Properties and mechanism. RSC Advances. 2024;14:12580–12592. DOI: 10.1039/d4ra00617h
151.AldawsariS, KampmannR, HarnischJ, RohdeC. Setting time, microstructure, and durability properties of low calcium fly ash/slag geopolymer: A review. Materials. 2022;15(3):876. DOI: 10.3390/ma15030876
152.DinhHL, LiuJ, DohJ, OngDEL. Influence of Si/Al molar ratio and ca content on the performance of fly ash-based geopolymer incorporating waste glass and GGBFS. Construction and Building Materials. 2024;411:134741. DOI: 10.1016/j.conbuildmat.2023.134741
153.KuenzelC, CisnerosJ, NevilleT, VandeperreL, SimonsS, BenstedJ, CheesemanC. Encapsulation of Cs/Sr contaminated clinoptilolite in geopolymers produced from metakaolin. Journal of Nuclear Materials. 2015;466:94–99. DOI: 10.1016/j.jnucmat.2015.07.034
154.JangJG, ParkS, LeeH-K. Physical barrier effect of geopolymeric waste form on diffusivity of cesium and strontium. Journal of Hazardous Materials. 2016;318:339–346. DOI: 10.1016/j.jhazmat.2016.07.003
155.DanH, DingY, WangE, YangW, HeX, ChenL, XianQ, YiF, ZhuW. Manganese dioxide-loaded mesoporous SBA-15 silica composites for effective removal of strontium from aqueous solution. Environmental Research. 2020;191:110040. DOI: 10.1016/j.envres.2020.110040
Written By
Amal I. Hassan, Hosam M. Saleh, Aleksandr S. Doroshkevich, Zhanna V. Mezentseva
Submitted: 15 June 2026Reviewed: 23 July 2026Published: 24 August 2026